Equity Overview
Price & Market Data
Price: $2.36
Daily Change: +$0.0909 / 3.85%
Daily Range: $2.36 - $2.37
Market Cap: $10,213,663
Daily Volume: 6,076
Performance Metrics
1 Week: 0.89%
1 Month: -14.34%
3 Months: -21.18%
6 Months: -43.25%
1 Year: -9.92%
YTD: -18.05%
Company Details
Employees: 24
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.